Basel Medical Group Ltd Ordinary Shares (BMGL) — Cash Flow Reinvestment Rate
Basel Medical Group Ltd Ordinary Shares (BMGL) has a Cash Flow Reinvestment Rate of 0.01x as of June 2024, reinvesting $15.84K (capex $7.92K plus investments $-7.92K) from operating cash flow of $2.51 Million. See cash generation quality of Basel Medical Group Ltd Ordinary Shares to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Basel Medical Group Ltd Ordinary Shares Cash Flow Reinvestment Rate (2022–2024)
Historical reinvestment intensity for Basel Medical Group Ltd Ordinary Shares across 3 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Basel Medical Group Ltd Ordinary Shares.
Annual Cash Flow Reinvestment Rate for Basel Medical Group Ltd Ordinary Shares (2022–2024)
Year-by-year capital reinvestment analysis for Basel Medical Group Ltd Ordinary Shares. See Basel Medical Group Ltd Ordinary Shares free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.01x | $15.84K | $2.51 Million | $7.92K | ▲ +33.2% |
| 2023 | 0.00x | $12.32K | $2.60 Million | $6.16K | ▼ -92.5% |
| 2022 | 0.06x | $176.99K | $2.79 Million | $88.50K | — |